Research Disease Areas [1]
We focus on discovering and advancing new treatments for serious patient needs. From the inception of a therapeutic through early clinical development, our disease area teams collaborate across scientific disciplines and organizations in support of our mission to improve and extend peoples’ lives.
Immuno-oncology
Our Immuno-oncology research program aims to treat most human cancers with immune therapy.
Oncology
Our Oncology group explores mechanisms and potential therapeutics for a wide range of both common and rare cancers.
Neuroscience
Learn how our recent advances in model systems and technology help us pursue revolutionary therapies for neurodegenerative, neurodevelopmental and neuropsychiatric conditions.
Cardiovascular & Metabolic Diseases
Concentrates on dyslipidemia, atherosclerosis and vascular diseases, type 2 diabetes, heart failure, cardiac arrhythmias and associated disorders.
Autoimmunity, Transplantation & Inflammatory Disease
Pioneers novel therapeutic modalities for the treatment of rheumatic and dermatological diseases as well as other auto-immune and inflammatory conditions.
Infectious Diseases
Investigates both viral infections, such as the hepatitis B virus, respiratory syncytial virus, and human cytomegalovirus, as well as on bacterial pathogens, such as Clostridium difficile, Staphylococcus aureus, and Pseudomonas aeruginosa.
Musculoskeletal Diseases
Researches muscle wasting associated with disuse due to cancer, chronic obstructive pulmonary disease, and aging, as well as andosteoporosis.
Ophthalmology
The ophthalmology team at NIBR is working on new scientific discoveries for eye disorders including age-related macular degeneration.
Respiratory Diseases
Concentrates on cystic fibrosis, idiopathic pulmonary fibrosis, pulmonary arterial hypertension, chronic obstructive pulmonary disease and asthma.